Hjem › Øcelleadenom › Illinois
Øcelleadenom kliniske forsøg i Illinois
5 studier for Øcelleadenom søger deltagere på steder i Illinois.
Byer i Illinois
Officiel studietekst (engelsk)
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Chicago
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06881992Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130), Chicago
- Northwestern Medicine Cancer Center - Warrenville ( Site 0134), Warrenville
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT04924075Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
- Memorial Hospital East, Shiloh
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT05687123Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. jan. 2026 · NCT06663072Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Saint Mary's Hospital, Centralia
- og 21 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. dec. 2025 · NCT05040360Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.